消息面上，康龙化成发布公告，为充分运用专业投资机构在生物医药行业内投资、研判的能力，公司的全资子公司 Pharmaron UK Limited(以下简称“康龙英国”)拟作为有限合伙人以自有资金认缴出资3000万美元参与投资 BLC Healthcare USD Fund I L.P.(以下简称“基金”或“合伙企业”)。2025年5月30日，康龙英国签署了《Amended and Restated Agreement of Exempted Limited Partnership of BLC Healthcare USD Fund I L.P.》(以下简称 “《合伙协议》”)。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.